Company Search:
Advanced Search
Sponsored Links
CASI Pharmaceuticals Inc Company Snapshot
CASI Pharmaceuticals Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares CASI Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Lineage Cell Therapeutics Inc (2019 sales of $3.52 million of which 100% was Synthetic Solutions), Organovo Holdings Incorporated ($3.09 million of which 100% was Developing and Commercializing Human Tis), and Titan Pharmaceuticals Inc ($3.61 million of which 100% was Pharmaceutical Products).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
CASI Pharmaceuticals Inc
  Stock Performance Chart for CASI Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 1.52
(Figures in U.S. Dollars)
1 Week -6.2%   13 Weeks -12.6%  
4 Weeks -39.7%   52 Weeks -54.1%  
CASI Pharmaceuticals Inc Key Data:
  Ticker: CASI Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 4,131,000
(Year Ending Jan 2020).
Employees: 126
  Currency: U.S. Dollars Market Cap: 153,411,820
  Fiscal Yr Ends: December Shares Outstanding: 100,928,829
  Share Type: Common Closely Held Shares: 52,979,443
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.